Invesco’s Edgewise Therapeutics EWTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$736K Buy
56,158
+8,028
+17% +$105K ﹤0.01% 2988
2025
Q1
$1.06M Buy
48,130
+4,695
+11% +$103K ﹤0.01% 2801
2024
Q4
$1.16M Sell
43,435
-21,341
-33% -$570K ﹤0.01% 2853
2024
Q3
$1.73M Buy
64,776
+42,532
+191% +$1.14M ﹤0.01% 2655
2024
Q2
$401K Buy
22,244
+1,098
+5% +$19.8K ﹤0.01% 3356
2024
Q1
$386K Buy
21,146
+4,618
+28% +$84.2K ﹤0.01% 3432
2023
Q4
$181K Sell
16,528
-6,447
-28% -$70.5K ﹤0.01% 3576
2023
Q3
$132K Buy
22,975
+11,252
+96% +$64.5K ﹤0.01% 3669
2023
Q2
$90.9K Sell
11,723
-140
-1% -$1.09K ﹤0.01% 3729
2023
Q1
$79.1K Sell
11,863
-1,004
-8% -$6.7K ﹤0.01% 3704
2022
Q4
$115K Buy
12,867
+969
+8% +$8.66K ﹤0.01% 3780
2022
Q3
$117K Sell
11,898
-64
-0.5% -$629 ﹤0.01% 3783
2022
Q2
$96K Sell
11,962
-4,945
-29% -$39.7K ﹤0.01% 3866
2022
Q1
$164K Buy
16,907
+390
+2% +$3.78K ﹤0.01% 3766
2021
Q4
$252K Buy
+16,517
New +$252K ﹤0.01% 3653